Richard Bernstein Advisors LLC Bristol Myers Squibb CO Transaction History
Richard Bernstein Advisors LLC
- $3.47 Billion
- Q3 2025
A detailed history of Richard Bernstein Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Richard Bernstein Advisors LLC holds 26,104 shares of BMY stock, worth $1.22 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,104
Previous 66,813
60.93%
Holding current value
$1.22 Million
Previous $3.09 Million
61.93%
% of portfolio
0.03%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...